EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Twenty-Three Years of Declining Lithium Use: Analysis of a Pharmacoepidemiological Dataset from German-Speaking Countries

Waldemar Greil iD, Mateo de Bardeci, Nadja Nievergelt, Sermin Toto, Renate Grohmann, Johanna Seifert, Georgios Schoretsanitis

Pharmacopsychiatry · 01.11.2024 · 57 (06) · 296-303

DOI: 10.1055/a-2374-2386 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacopsychiatry, erschienen am 01.11.2024. Verfasst von Waldemar Greil und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry and Psychotherapy, LMU University Hospital, LMU Munich, Germany. Hauptthemen laut MEDLINE: Pharmacoepidemiology. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Pharmacoepidemiological data suggest that lithium prescriptions for bipolar disorder are gradually decreasing, with less attention having been paid to other indications.

Methods

We examined lithium prescriptions between 1994 and 2017 in data provided by the Drug Safety in Psychiatry Program AMSP, including psychiatric hospitals in Germany, Austria and Switzerland. We compared lithium use for different diagnoses before and after 2001 and in three periods (T1: 1994–2001, T2: 2002–2009, and T3: 2010–2017).

Results

In a total of 158,384 adult inpatients (54% female, mean age 47.4±17.0 years), we observed a statistically significant decrease in lithium prescriptions between 1994–2000 and 2001–2017 in patients with schizophrenia spectrum disorder from 7.7% to 5.1% and in patients with affective disorders from 16.8% to 9.6%. Decreases in use were also observed for diagnostic subgroups: schizoaffective disorder (ICD-10 F25: 27.8% to 17.4%), bipolar disorder (F31: 41.3% to 31%), depressive episode (F32: 8.1% to 3.4%), recurrent depression (F33: 17.9% to 7.5%, all: p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PharmacoepidemiologyHumansFemaleMaleMiddle AgedAdultGermanySwitzerlandAustriaBipolar DisorderLithium CompoundsAntimanic AgentsAgedDrug Prescriptions

Substanzen

Lithium CompoundsAntimanic Agents

Autor:innen und Institutionen

  • Department of Psychiatry and Psychotherapy, LMU University Hospital, LMU Munich, Germany.
  • Psychiatric Private Hospital, Sanatorium Kilchberg, Zurich, Switzerland.
  • Department of Psychiatry, Psychotherapy and Psychosomatics, Hospital of Psychiatry, University of Zurich, Zurich, Switzerland.
  • Department of Psychiatry, Social Psychiatry and Psychotherapy, Hannover Medical School, Hannover, Germany.
  • The Zucker Hillside Hospital, Psychiatry Research, Northwell Health, Glen Oaks, New York, USA.
  • Department of Psychiatry at the Donald and Barbara Zucker School of Medicine at Northwell/Hofstra, Hempstead, NY, USA.

ORCID-Profile: Waldemar Greil

Zitieren

APA

Greil, W., de Bardeci, M., Nievergelt, N., Toto, S., Grohmann, R., Seifert, J., & Schoretsanitis, G. (2024). Twenty-Three Years of Declining Lithium Use: Analysis of a Pharmacoepidemiological Dataset from German-Speaking Countries. Pharmacopsychiatry, 57(06), 296-303. https://doi.org/10.1055/a-2374-2386

Vancouver

Greil W, de Bardeci M, Nievergelt N, Toto S, Grohmann R, Seifert J, et al. Twenty-Three Years of Declining Lithium Use: Analysis of a Pharmacoepidemiological Dataset from German-Speaking Countries. Pharmacopsychiatry. 2024;57(06):296-303. doi:10.1055/a-2374-2386

BibTeX
@article{Greil2024,
  author = {Greil, Waldemar and de Bardeci, Mateo and Nievergelt, Nadja and Toto, Sermin and Grohmann, Renate and Seifert, Johanna and Schoretsanitis, Georgios},
  title = {Twenty-Three Years of Declining Lithium Use: Analysis of a Pharmacoepidemiological Dataset from German-Speaking Countries},
  journal = {Pharmacopsychiatry},
  year = {2024},
  volume = {57},
  number = {06},
  pages = {296--303},
  doi = {10.1055/a-2374-2386}
}
Kostenlos starten →